THE ROLE OF SOYBEANS IN CANCER PREVENTION AND MANAGEMENT
Keywords:
Soybeans, Isoflavones, Anticancer Properties, Breast Cancer, Prostate Cancer, Dietary InterventionAbstract
Cancer is a huge worldwide health concern, and dietary treatments have gained importance as a viable tool for prevention and management. Soybeans, rich in isoflavones and other bioactive chemicals, have been widely examined for their anticancer potential. This review synthesizes current studies on the role of soybeans in cancer prevention and treatment, emphasizing their bioactive components, modes of action, and therapeutic implications. Soy isoflavones, notably genistein and daidzein, display antioxidant, anti-inflammatory, and anticancer effects, reducing cancer cell growth, inducing apoptosis, and lowering angiogenesis. Epidemiological studies have repeatedly linked increased soy diet to lower chances of hormone-related malignancies, including breast and prostate cancer. The mechanisms behind these benefits include control of estrogen metabolism, antioxidant capabilities, and immune system stimulation. Furthermore, the incorporation of soy isoflavones with traditional cancer therapy has been recommended to boost therapeutic effectiveness while lowering toxicity. This analysis shows the potential of soybeans as a beneficial component in dietary regimens for cancer prevention and control, with implications for individualized dietary advice and integrative oncology.
References
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology. 2022;95(1130):20211033.
Chatterjee A, Prinz A, Gerdes M, Martinez S. Digital interventions on healthy lifestyle management: systematic review. Journal of Medical Internet Research. 2021;23(11):e26931.
Verma MK, Singh BK, Tripathi M. Benefits of Phytoestrogens. In: Herbs and Spices-New Perspectives in Human Health and Food Industry. 2024. p. 109.
Boye A, Osei SA, Brah AS. Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers. Biomedicine & Pharmacotherapy. 2024;180:117473.
Ferriere F, Aasi N, Flouriot G, Pakdel F. Exploring the Complex Mechanisms of Isoflavones: From Cell Bioavailability, to Cell Dynamics and Breast Cancer. Phytotherapy Research. 2024.
Liu F, Peng Y, Qiao Y, Huang Y, Song F, Zhang M, Song F. Consumption of flavonoids and risk of hormone-related cancers: a systematic review and meta-analysis of observational studies. Nutrition Journal. 2022;21(1):27.
Wan ML, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Critical Reviews in Food Science and Nutrition. 2022;62(24):6549-6576.
Wang Z, Liu Z, Qu J, Sun Y, Zhou W. Role of natural products in tumor therapy from basic research and clinical perspectives. Acta Materia Medica. 2024;3(2):163-206.
Ulusoy-Gezer HG, Rakıcıoğlu N. The Future of Obesity Management through Precision Nutrition: Putting the Individual at the Center. Current Nutrition Reports. 2024:1-23.
Manayi A. Soybeans and phytoestrogen rich foods (Genistein, Daidzein) against cancer. In: Nutraceuticals and Cancer Signaling: Clinical Aspects and Mode of Action. 2021. p. 419-449.
Orzołek I, Sobieraj J, Domagała-Kulawik J. Estrogens, cancer and immunity. Cancers. 2022;14(9):2265.
Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Xiong W. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research. 2020;39:1-19.
Daman R, Miglani M. Genistein: A Multifaceted Flavonoid with Diverse Medicinal Applications.
Goh YX, Jalil J, Lam KW, Husain K, Premakumar CM. Genistein: A review on its anti-inflammatory properties. Frontiers in Pharmacology. 2022;13:820969.
Konstantinou EK, Gioxari A, Dimitriou M, Panoutsopoulos GI, Panagiotopoulos AA. Molecular Pathways of Genistein Activity in Breast Cancer Cells. International Journal of Molecular Sciences. 2024;25(10):5556.
Tuli HS, Tuorkey MJ, Thakral F, Sak K, Kumar M, Sharma AK, Bishayee A. Molecular mechanisms of action of genistein in cancer: Recent advances. Frontiers in Pharmacology. 2019;10:1336.
Qiu S, Jiang C. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis. European Journal of Nutrition. 2019;58:3079-3090.
Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T, Toyooka S. Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments. Breast Cancer Research and Treatment. 2021;185:307-316.
Xiang D, Liu Y, Zhou S, Zhou E, Wang Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxidative Medicine and Cellular Longevity. 2021;2021(1):5523516.
Yang L, Yao Y, Bai Y, Zheng D, Zhou F, Chen L, Zhao C. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway. Phytomedicine. 2021;80:153366.
Khankari NK, Yang JJ, Sawada N, Wen W, Yamaji T, Gao J, Zheng W. Soy intake and colorectal cancer risk: results from a pooled analysis of prospective cohort studies conducted in China and Japan. The Journal of Nutrition. 2020;150(9):2442-2450.
Wei Q, Zhang YH. Flavonoids with Anti-Angiogenesis Function in Cancer. Molecules. 2024;29(7):1570.
Ullah A, Arif M, Waqas M, Hasnain M, Saira A, Rariq R, Khaliq H. Exploring the Role of Chemicals and Environmental Factors for Cancer Proliferation. Open Access Library Journal. 2024;11(12):1-19.
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemporary Oncology/Współczesna Onkologia. 2021;25(1):45-52.
Sengupta S, Gill V, Mellinger JL. Alcohol-associated liver disease and public health policies. Hepatology. 2024;80(6):1323-1341.
Perdomo CM, Avilés-Olmos I, Dicker D, Frühbeck G. Towards an adiposity-related disease framework for the diagnosis and management of obesities. Reviews in Endocrine and Metabolic Disorders. 2023;24(5):795-807.
Rodgers KM, Udesky JO, Rudel RA, Brody JG. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environmental Research. 2018;160:152-182.
Kay JE, Cardona B, Rudel RA, Vandenberg LN, Soto AM, Christiansen S, Fenton SE. Chemical effects on breast development, function, and cancer risk: existing knowledge and new opportunities. Current Environmental Health Reports. 2022;9(4):535-562.
Hosseini B, Hall AL, Zendehdel K, Kromhout H, Onyije FM, Moradzadeh R, Olsson A. Occupational exposure to carcinogens and occupational epidemiological cancer studies in Iran: a review. Cancers. 2021;13(14):3581.
Muñoz A, Grant WB. Vitamin D and cancer: an historical overview of the epidemiology and mechanisms. Nutrients. 2022;14(7):1448.
Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Annals of Oncology. 2019;30(5):733-743.
Wang M, Yang Y, Liao Z. Diabetes and cancer: Epidemiological and biological links. World Journal of Diabetes. 2020;11(6):227.
Abudawood M. Diabetes and cancer: a comprehensive review. Journal of Research in Medical Sciences. 2019;24(1):94.
Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathology-Research and Practice. 2021;227:153641.
Messina M. Impact of soy foods on the development of breast cancer and the prognosis of breast cancer patients. Forschende Komplementärmedizin/Research in Complementary Medicine. 2016;23(2):75-80.
Boutas I, Kontogeorgi A, Dimitrakakis C, Kalantaridou SN. Soy isoflavones and breast cancer risk: a meta-analysis. In Vivo. 2022;36(2):556-562.
Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Fergusson D. Soy, red clover, and isoflavones and breast cancer: a systematic review. PLOS ONE. 2013;8(11):e81968.
Fraser GE, Jaceldo-Siegl K, Orlich M, Mashchak A, Sirirat R, Knutsen S. Dairy, soy, and risk of breast cancer: those confounded milks. International Journal of Epidemiology. 2020;49(5):1526-1537.
Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H, Li L. Soy intake and breast cancer risk: A prospective study of 300,000 Chinese women and a dose-response meta-analysis. European Journal of Epidemiology. 2020;35:567-578.
Zhang G, Wang Y, Zhang Y, Wan X. Soy intake and breast cancer risk: A prospective study in Chinese women and a dose-response meta-analysis. European Journal of Epidemiology. 2020;35(5):567-578
Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012;96(1):123-32.
Kim IS. Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans. Antioxidants. 2021;10(7):1064.
Chen X, Chen X, Li J, et al. Impact of dietary soy intake on cancer incidence: A meta-analysis. J Nutr Oncol. 2022;15(3):456–68.
Şahin A, Yılmaz M, Durmuş F. Phytoestrogens in cancer therapy: A focus on genistein. J Cancer Prev. 2019;14(4):389–403.
Tian W, Ma S, Zhang Y, et al. Genistein and chemotherapy: Mechanisms of action and clinical applications. Mol Oncol. 2015;9(7):1345–1357.
Amaral C, Toloi MRT, Vasconcelos LD, Fonseca MJV, Correia-da-Silva G, Teixeira N. The role of soybean extracts and isoflavones in hormone-dependent breast cancer: aromatase activity and biological effects. Food Funct. 2017;8(9):3064-3074.
Lei YY, Ho SC, Cheng A, Kwok C, Cheung KL, He YQ, et al. The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients. Breast Cancer Res Treat. 2020;181:167-80.
Wei Q, Zhang YH. Flavonoids with Anti-Angiogenesis Function in Cancer. Molecules. 2024;29(7):1570.
Sim EJ, Ko KP, Ahn C, Park SM, Surh YJ, An S, et al. Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer. Breast Cancer Res Treat. 2020;184:615-26.
Lee H, Zhang H, Pang J, et al. The role of genetic polymorphisms in isoflavone metabolism: Implications for cancer therapy. Pers Med Oncol. 2021;18(2):250–65.
Blázovics A, Csorba B, Ferencz A. The beneficial and adverse effects of phytoestrogens. OBM Integr Complement Med. 2022;7(3):1-35.
Applegate CC, Rowles III JL, Ranard KM, Jeon S, Erdman Jr JW. Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients. 2018;10(1):40.
Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review. Asian J Urol. 2020;7(3):191-202.
Sivoňová MK, Kaplán P, Tatarková Z, Lichardusová L, Dušenka R, Jurečeková J. Androgen receptor and soy isoflavones in prostate cancer. Mol Clin Oncol. 2019;10(2):191-204.
Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020;58(3):326-39.
Zaheer K, Humayoun Akhtar M. An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health. Crit Rev Food Sci Nutr. 2017;57(6):1280-93.
Gupta N, Patel HD, Taylor J, Borin JF, Jacobsohn K, Kenfield SA, et al. Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. Prostate Cancer Prostatic Dis. 2022;25(3):444-52.
Huang Y, Wang W, Jin J. Association between soy products and prostate cancer: A systematic review and meta-analysis of observational studies. Invest Clin Urol. 2024;65(6):540.
Chung BH, Horie S, Chiong E. The incidence, mortality, and risk factors of prostate cancer in Asian men. Prostate Int. 2019;7(1):1-8.
Abbaszadeh H, Keikhaei B, Mottaghi S. A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds. Phytother Res. 2019;33(8):2002-14.
Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, Włodarek D, Gromadzka-Ostrowska J. Dietary factors and prostate cancer development, progression, and reduction. Nutrients. 2021;13(2):496.
Aboushanab SA, Khedr SM, Gette IF, Danilova IG, Kolberg NA, Ravishankar GA, et al. Isoflavones derived from plant raw materials: Bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation. Crit Rev Food Sci Nutr. 2022;63(2):261-87.
Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98(1):9-14.
Fan J, Li Q, Pang W, et al. Soy isoflavones and cancer prevention: A comprehensive review. Nutr Cancer. 2022;74(2):123–40.
Bu Y, Qu J, Ji S, Zhou J, Xue M, Qu J, et al. Dietary patterns and breast cancer risk, prognosis, and quality of life: A systematic review. Front Nutr. 2023;9:1057057.
Tâlvan CD, Budișan L, Tâlvan ET, Grecu V, Zănoagă O, Mihalache C, et al. Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer. Cancers. 2024;16(4):745.
Janiszewska J, Ostrowska J, Szostak-Węgierek D. The influence of nutrition on adiponectin: A narrative review. Nutrients. 2021;13(5):1394.
Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021(1):3268136.
Shin S, Fu J, Shin WK, Huang D, Min S, Kang D. Association of food groups and dietary pattern with breast cancer risk: A systematic review and meta-analysis. Clin Nutr. 2023;42(3):282-97.
Cao S, Liu L, Zhu Q, Zhu Z, Zhou J, Wei P, Wu M. Adherence to the vegetable-fruit-soy dietary pattern, a reference from mediterranean diet, protects against postmenopausal breast cancer among Chinese women. Front Nutr. 2022;9:800996.
Alkadi H. A review on free radicals and antioxidants. Infect Disord Drug Targets. 2020;20(1):16-26.
Tubbs A, Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168(4):644-656.
Lambert JD, Sang S, Yang CS. Biotransformation of isoflavones and the enhancement of bioavailability. Am J Clin Nutr. 2007;85(4):1137-1145.
Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021(1):3268136.
Wójciak M, Drozdowski P, Ziemlewska A, Zagórska-Dziok M, Nizioł-Łukaszewska Z, Kubrak T, Sowa I. ROS Scavenging Effect of Selected Isoflavones in Provoked Oxidative Stress Conditions in Human Skin Fibroblasts and Keratinocytes. Molecules. 2024;29(5):955.
Nwachukwu ID, Sarteshnizi RA, Udenigwe CC, Aluko RE. A concise review of current in vitro chemical and cell-based antioxidant assay methods. Molecules. 2021;26(16):4865.
Akyüz M, İnci Ş, Kırbağ S. Evaluation of Antimicrobial, Antioxidant, Cytotoxic and DNA Protective Effects of Oyster Mushroom: Pleurotus pulmonarius (Fr.) Quel. Arab J Sci Eng. 2023;48(6):7273-83.
Hamad D, El-Sayed H, Ahmed W, Sonbol H, Ramadan MAH. GC-MS analysis of potentially volatile compounds of Pleurotus ostreatus polar extract: in vitro antimicrobial, cytotoxic, immunomodulatory, and antioxidant activities. Front Microbiol. 2022;13:834525.
Qiao Y, Zhang K, Zhang Z, Zhang C, Sun Y, Feng Z. Fermented soybean foods: A review of their functional components, mechanism of action and factors influencing their health benefits. Food Res Int. 2022;158:111575.
Król-Grzymała A, Amarowicz R. Phenolic compounds of soybean seeds from two European countries and their antioxidant properties. Molecules. 2020;25(9):2075.
Li X, Li S, Wang J, Chen G, Tao X, Xu S. Metabolomic analysis reveals domestication-driven reshaping of polyphenolic antioxidants in soybean seeds. Antioxidants. 2023;12(4):912.
Gupta R, Ambasta RK, Kumar P. Autophagy and apoptosis cascade: which is more prominent in neuronal death? Cellular and molecular life sciences. 2021;78(24):8001-47.
He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K/Akt signal transduction for cancer therapy. Signal transduction and targeted therapy. 2021;6(1):425.
Konstantinou EK, Gioxari A, Dimitriou M, Panoutsopoulos GI, Panagiotopoulos AA. Molecular pathways of genistein activity in breast cancer cells. International Journal of Molecular Sciences. 2024;25(10):5556.
Chae HS, Xu R, Won JY, Chin YW, Yim H. Molecular targets of genistein and its related flavonoids to exert anticancer effects. International Journal of Molecular Sciences. 2019;20(10):2420.
Sivoňová MK, Kaplán P, Tatarková Z, Lichardusová L, Dušenka R, Jurečeková J. Androgen receptor and soy isoflavones in prostate cancer. Molecular and clinical oncology. 2019;10(2):191-204.
Kaufman‐Szymczyk A, Jalmuzna J, Lubecka‐Gajewska K. Soy‐derived isoflavones as chemo‐preventive agents targeting multiple signalling pathways for cancer prevention and therapy. British Journal of Pharmacology. 2024;181(11):2401-2415.
Fernández-Tomé S, Xu F, Han Y, Hernández-Ledesma B, Xiao H. Inhibitory effects of peptide lunasin in colorectal cancer HCT-116 cells and their tumorsphere-derived subpopulation. International Journal of Molecular Sciences. 2020;21(2):537.
Zappavigna S, Cossu AM, Grimaldi A, Bocchetti M, Ferraro GA, Nicoletti GF, Filosa R, Caraglia M. Anti-inflammatory drugs as anticancer agents. International Journal of Molecular Sciences. 2020;21(7):2605.
Matthews HK, Bertoli C, de Bruin RA. Cell cycle control in cancer. Nature reviews Molecular cell biology. 2022;23(1):74-88.
Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. Seminars in cancer biology. 2018;51:149-159.
Acharjee S, Chauhan S, Pal R, Tomar RS. Mechanisms of DNA methylation and histone modifications. Progress in molecular biology and translational science. 2023;197:51-92.
Zhao P, Malik S. The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes. Cell & Bioscience. 2022;12(1):83.
Sharma M, Arora I, Chen M, Wu H, Crowley MR, Tollefsbol TO, Li Y. Therapeutic effects of dietary soybean genistein on triple-negative breast cancer via regulation of epigenetic mechanisms. Nutrients. 2021;13(11):3944.
Akone SH, Ntie-Kang F, Stuhldreier F, Ewonkem MB, Noah AM, Mouelle SE, Müller R. Natural products impacting DNA methyltransferases and histone deacetylases. Frontiers in Pharmacology. 2020;11:992.
Dutta B, Park JE, Qing ITY, Kon OL, Sze SK. Soy‐Derived Phytochemical Genistein Modifies Chromatome Topology to Restrict Cancer Cell Proliferation. Proteomics. 2018;18(16):1700474.
Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Scarpati GD, Di Lorenzo G, Pisconti S. Epigenetic control of gene expression: Potential implications for cancer treatment. Critical reviews in oncology/hematology. 2017;111:166-72.
Ziaei S, Halaby R. Dietary isoflavones and breast cancer risk. Medicines. 2017;4(2):18.
Eren E, Das J, Tollefsbol TO. Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer. Nutrients. 2024;16(23):4143.
Ajdžanovic V, Filipovic B, Miljic D, Mijatovic S, Maksimovic-Ivanic D, Miler M, Živanovic J, Miloševic V. Prostate cancer metastasis and soy isoflavones: a dogfight over a bone. EXCLI journal. 2019;18:106.
Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017;8(10):17216.
Jeong SH, Kim HH, Park MY, Bhosale PB, Abusaliya A, Hwang KH, Moon YG, Heo JD, Seong JK, Ahn M, Park KI. Potential Anticancer Effects of Isoflavone Prunetin and Prunetin Glycoside on Apoptosis Mechanisms. International Journal of Molecular Sciences. 2024;25(21):11713.
Sarkar B, Ullah MA, Islam SS, Rahman MH, Araf Y. Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2. Journal of Receptors and Signal Transduction. 2021;41(3):217-33.
Ivashkevich A. Genistein in cancer therapy: A review of its potential as a radiosensitizer and chemoprotective agent. Cancer Therapy Reviews. 2023;20(1):1-10.
Messina M, Mejia SB, Cassidy A, Duncan A, Kurzer M, Nagato C, Ronis M, Rowland I, Sievenpiper J, Barnes S. Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: a technical review of the observational and clinical data. Critical Reviews in Food Science and Nutrition. 2022;62(21):5824-85.
Subedi L, Lee JH, Yumnam S, Ji E, Kim SY. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-κB inhibition and Nrf2/HO-1 activation. Cells. 2019;8(2):194.
Komorowska D, Radzik T, Kalenik S, Rodacka A. Natural radiosensitizers in radiotherapy: cancer treatment by combining ionizing radiation with resveratrol. International Journal of Molecular Sciences. 2022;23(18):10627.
Bai R, Chen N, Li L, Du N, Bai L, Lv Z, Tian H, Cui J. Mechanisms of cancer resistance to immunotherapy. Frontiers in oncology. 2020;10:1290.
Goleij P, Tabari MA, Khandan M, Poudineh M, Rezaee A, Sadreddini S, Sanaye PM, Khan H, Larsen DS, Daglia M. Genistein in focus: pharmacological effects and immune pathway modulation in cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;1-5.
Čoma M, Lachová V, Mitrengová P, Gál P. Molecular changes underlying genistein treatment of wound healing: a review. Current Issues in Molecular Biology. 2021;43(1):127-41.
Rani P, Yu X, Liu H, Li K, He Y, Tian H, Kumar R. Material, antibacterial and anticancer properties of natural polyphenols incorporated soy protein isolate: A review. European Polymer Journal. 2021;152:110494.
Mia MA, Dey D, Sakib MR, Biswas MY, Prottay AA, Paul N, Rimti FH, Abdullah Y, Biswas P, Iftehimul M, Paul P. The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities. Phytotherapy Research. 2023;37(12):5724-54.
Kaufman‐Szymczyk A, Jalmuzna J, Lubecka‐Gajewska K. Soy‐derived isoflavones as chemo‐preventive agents targeting multiple signalling pathways for cancer prevention and therapy. British Journal of Pharmacology. 2024;181(11):2401-2415.
Ashrafi-Dehkordi E, Tahmasebi A, Zare H, Mazloomi SM. A meta-analysis of transcriptome data to investigate the effect of soy isoflavones on breast cancer cell. Iranian Journal of Biotechnology. 2024;22(2):e3762.
Sauter ER. Cancer prevention and treatment using combination therapy with natural compounds. Expert review of clinical pharmacology. 2020;13(3):265-85.
Wang H, Zhang K, Liu J, Yang J, Tian Y, Yang C, Li Y, Shao M, Su W, Song N. Curcumin regulates cancer progression: Focus on ncRNAs and molecular signaling pathways. Frontiers in oncology. 2021;11:660712.
Coutinho AJ, Pinheiro M, Neves AR, Pinto MM. Therapeutic potential of genistein: preclinical studies, clinical evidence, and nanotechnology application. Current Medicinal Chemistry. 2023;30(22):2480-517.
Gan RY, Li HB, Sui ZQ, Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical reviews in food science and nutrition. 2018;58(6):924-41.
Ohishi T, Miyoshi N, Mori M, Sagara M, Yamori Y. Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels. Molecules. 2022;27(24):8899.
Kundur S, Prayag A, Selvakumar P, Nguyen H, McKee L, Cruz C, Srinivasan A, Shoyele S, Lakshmikuttyamma A. Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines. Journal of cellular physiology. 2019;234(7):11103-18.
Mokra D, Joskova M, Mokry J. Therapeutic effects of green tea polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. International journal of molecular sciences. 2022;24(1):340.
Kursvietiene L, Kopustinskiene DM, Staneviciene I, Mongirdiene A, Kubová K, Masteikova R, Bernatoniene J. Anti-cancer properties of resveratrol: a focus on its impact on mitochondrial functions. Antioxidants. 2023;12(12):2056.
Tuli HS, Tuorkey MJ, Thakral F, Sak K, Kumar M, Sharma AK, et al. Molecular mechanisms of action of genistein in cancer: Recent advances. Frontiers in pharmacology. 2019;10:1336.
Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735.
Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):5474.
Sharma M, Tollefsbol TO. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition. Experimental cell research. 2022;416(1):113160.
Mahn A, Castillo A. Potential of sulforaphane as a natural immune system enhancer: A review. Molecules. 2021;26(3):752.
Downloads
Published
Data Availability Statement
Data available on request
